Biotech firm Roivant Sciences to go public via $7.3 billion SPAC deal reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
December 23, 2020
The race for a Covid-19 vaccine isn’t over, but its first leg has finally ended. And the pharmaceutical industry hasn’t delivered just one winner: Against all odds, it’s a tie.
On Dec. 18, Moderna became the second company to have its Covid-19 vaccine receive emergency use authorization (pdf) in the US. The US Food and Drug Administration (FDA) gave it the green light a little over a week after it authorized Pfizer and BioNTech’s Covid-19 vaccine. Britain and Canada have also authorized the Pfizer/BioNTech jab, while the European Union did so on Dec. 21, signaling the beginning of the end of the Covid-19 pandemic, as these rich developed nations take on the Herculean task of vaccinating more than 800 million people.